申请人:Bhattacharya Kumar Samit
公开号:US20070270438A1
公开(公告)日:2007-11-22
The invention relates to compounds of formula I
and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R
1
, R
2
, R
3
, R
4
, R
5
, R
8
, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
该发明涉及公式I的化合物及其药学上可接受的盐、前药、溶剂合物或水合物;其中B、D、E、R1、R2、R3、R4、R5、R8、m、n、p、q、r、s、t和u的定义如本文所述。该发明还涉及一种在哺乳动物,尤其是人类中,治疗增殖过度性疾病和自身免疫疾病的方法,以及含有这种化合物的药物组合物。